Selected data models

You must log in to select data models for download or further analysis.

8 Search results.
Relevance Rating New first Old first

Pancreatic Cancer NCT00733746 Registration - ACOSOG-Z5041 Registration Worksheet - 2921129v1.0 - ACOSOG-Z5041 Registration Worksheet

- 9/20/21 - 1 form, 4 itemgroups, 34 items, 1 language
Itemgroups: Header Module, Eligibility Criteria, Diagnosis and Therapy, Specimen Banking Consent
ACOSOG-Z5041 Registration Worksheet Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6F3D4C5B-FB42-7755-E040-BB89AD432E97

Pancreatic Cancer NCT00733746 Registration - Z5041 - OPEN Enrollment Form - 3013792v1.0 - Z5041 - OPEN Enrollment Form

- 9/17/21 - 1 form, 3 itemgroups, 44 items, 1 language
Itemgroups: Demography Section, General Information, Eligibility Checklist
Z5041 - OPEN Enrollment Form Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7FFA1514-8347-A58F-E040-BB89AD4376E5

Pancreatic Cancer NCT00075686 Pre-Study - S0205 Advanced GI Carcinoma Prestudy Form - 2035482v3.0 - S0205 Advanced GI Carcinoma Prestudy Form

- 1/9/15 - 1 form, 5 itemgroups, 19 items, 1 language
Itemgroups: Header, DESCRIPTION OF DISEASE, PRIOR TREATMENT RELATED TO THIS CANCER, Comments, CCRR MODULE
S0205 Advanced GI Carcinoma Prestudy Form S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A11A5640-9768-6C93-E034-080020C9C0E0

Pancreatic Cancer NCT01473303 Registration - CALGB-81003 OPEN Registration Worksheet (SPARE Phase Ib) - 3340712v1.0 - CALGB-81003 OPEN Registration Worksheet (SPARE Phase Ib)

- 1/9/15 - 1 form, 8 itemgroups, 22 items, 1 language
Itemgroups: Protocol Administration, Pre-Treatment Characteristics, Certification Of Eligibility, Protocol Design, Prior Cancer Therapies, Study 71102: Patient-reported Outcomes Companion Study, Study 151109: Blood and Tumor Biomarker Companion Study and Study 61103: PG and PK Companion Study, Companion Studies
CALGB-81003 OPEN Registration Worksheet (SPARE Phase Ib) Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B5545048-A6BC-B965-E040-BB89AD437802

Pancreatic Cancer NCT01473303 Registration - CALGB-81003 OPEN Registration Worksheet (Phase II) - 3297544v1.0 - CALGB-81003 OPEN Registration Worksheet (Phase II)

- 1/9/15 - 1 form, 8 itemgroups, 22 items, 1 language
Itemgroups: Protocol Administration, Pre-Treatment Characteristics, Certification Of Eligibility, Protocol Design, Prior Cancer Therapies, Study 71102: Patient-reported Outcomes Companion Study, Study 151109: Blood and Tumor Biomarker Companion Study and Study 61103: PG and PK Companion Study, Companion Studies
CALGB-81003 OPEN Registration Worksheet (Phase II) Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B0263E2E-A570-C223-E040-BB89AD4317AC

Pancreatic Cancer NCT00075686 Pre-Study - S0205 Advanced Pancreas Carcinoma Prestudy Form - 2307178v3.0 - S0205 Advanced Pancreas Carcinoma Prestudy Form

- 1/9/15 - 1 form, 4 itemgroups, 33 items, 1 language
Itemgroups: Header, DESCRIPTION OF DISEASE, Prior Treatment Related to This Cancer, Comments
S0205 Advanced Pancreas Carcinoma Prestudy Form S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F2EB1888-EFD9-210C-E034-0003BA3F9857

S0205 Registration Form NCT00075686

- 9/20/21 - 1 form, 4 itemgroups, 29 items, 1 language
Itemgroups: SWOG clinical trial administrative data, Patient demographics, Comments, CCRR MODULE
S0205 Registration Form NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A11C9703-C8D4-1BF2-E034-080020C9C0E0

Prostate Cancer NCT01251861 Pre-Study - E2809 Registration Worksheet (step 1) - 3153226v1.0 - E2809 Registration Worksheet (step 1)

- 1/9/15 - 1 form, 1 itemgroup, 11 items, 1 language
Itemgroup: Eligibility
E2809 Registration Worksheet (step 1) Bicalutamide With or Without MK2206 in Treating Patients With Previously Treated Prostate Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=93A7565E-608E-32A1-E040-BB89AD436B02

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial